The estimated Net Worth of Jason W. Myers is at least $32.5 Million dollars as of 23 December 2020. Jason Myers owns over 174,152 units of Invitae Corp stock worth over $8,212 and over the last 4 years he sold NVTA stock worth over $32,524,788. In addition, he makes $0 as Director at Invitae Corp.
Jason has made over 3 trades of the Invitae Corp stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 174,152 units of NVTA stock worth $8,869,561 on 23 December 2020.
The largest trade he's ever made was selling 253,912 units of Invitae Corp stock on 14 December 2020 worth over $12,058,281. On average, Jason trades about 130,606 units every 2 days since 2020. As of 23 December 2020 he still owns at least 410,597 units of Invitae Corp stock.
You can see the complete history of Jason Myers stock trades at the bottom of the page.
Dr. Jason W. Myers Ph.D. serves as Director of the Company. He is ArcherDX’s co-founder and served as President and Chief Executive Officer and as a member of ArcherDX’s board of directors from January 2015 through the completion of the Merger. From August 2013 to January 2015, prior to ArcherDX’s spin-off from Enzymatics, Inc., Dr. Myers served as Chief Scientific Officer of Enzymatics, Inc. Dr. Myers received his BASc. in Biochemistry and Molecular Biology from the Colorado State University and his Ph.D. in Molecular Pharmacology from Stanford University School of Medicine.
Jason Myers is 45, he's been the Director of Invitae Corp since 2020. There are 17 older and 2 younger executives at Invitae Corp. The oldest executive at Invitae Corp is Dr. Robert L. Nussbaum, 71, who is the Chief Medical Officer.
Jason's mailing address filed with the SEC is C/O INVITAE CORPORATION, 1400 16TH STREET, SAN FRANCISCO, CA, 94103.
Over the last 10 years, insiders at Invitae Corp have traded over $68,349,838 worth of Invitae Corp stock and bought 2,982,686 units worth $18,086,236 . The most active insiders traders include Bros. Advisors Lp Baker Bro..., Bros. Advisors Lpbaker Feli..., and James E Deerfield Mgmt L.P..... On average, Invitae Corp executives and independent directors trade stock every 14 days with the average trade being worth of $540. The most recent stock trade was executed by Robert L Nussbaum on 13 June 2023, trading 7,086 units of NVTA stock currently worth $9,779.
invitae is a genetic information company whose mission is to bring genetic information into routine medical practice to improve the quality of healthcare for billions of people. specializing in genetic diagnostics for hereditary disorders, invitae is aggregating the world’s genetic tests into a single service with better quality, faster turnaround time, and a lower price than most single-gene diagnostic tests today. choose from our curated panels or design your own test for the same low price. today, we are reinventing genetic testing by lowering the barriers for clinicians and patients to obtain diagnostic genetic information. together we can improve healthcare for billions of people.
Invitae Corp executives and other stock owners filed with the SEC include: